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Abstract
In Cuba, previous reports have shown an increase of epidemic KS, reaching a total of 120 cases by the end of
2007, despite the use of HAART. To evaluate and compare the role of human herpes virus 8 (HHV-8) viral loads in
different compartments of AIDS-related Kaposi’s sarcoma (AIDS-KS) patients real-time polymerase chain reaction
(RT-PCR) was used to determine the genome copy number of HHV-8 in plasma, saliva, tissue and peripheral blood
mononuclear cells (PBMC) of 49 AIDS-KS patients. Overall, 98% of AIDS-KS patients harbored detectable HHV-8.
HHV-8 could be detected in 91.6% of KS tissue lesions showing the highest viral load (median log = 3.14 copies/
100 ng DNA) followed by saliva and PBMC which were positive in 78%, and 69.2%; respectively. In contrast, HHV-8
was detected in only 37% of plasma samples, which also showed lower viral loads. Men who had sex with men
(MSM) were more likely to have three-times higher HHV-8 genome copies in KS lesions when compared with tis-
sues from heterosexuals individuals (OR 3; 95% CI 1.1 to 12.5). These results emphasize the systemic nature of HHV-
8-infection and demonstrate the possible role of saliva in HHV-8 transmission among MSM.
Findings
One hundred and forty-two clinical samples belonging
to 49 patients with epidemic KS histologically diagnosed
in the Pathology Department at the Institute of Tropical
Medicine Pedro Kourí between 2004-2007 were
included. The research was approved by local and
national ethics committees; all subjects provided their
written informed consent. Clinical, immunological and
epidemiological data from each patient are depicted in
Table 1.
Different types of samples (41 saliva, 48 tissues, 26
PBMC, and 27 plasma) obtained from each individual
were tested at the same time. PBMC and plasma were
obtained by separation of 20 mL of citrated whole blood
using a Ficoll separation gradient (SIGMA, UK). Paraffin
was removed from tissues by xylene treatment according
to published protocols [1]. DNA extraction was
performed using the QIAamp® DNA Mini Kit (QIAGEN,
Germany) and the genomic DNA (gDNA) concentration
was determined using spectrophotometer (GeneQuant
II, Pharmacia Biotech, EUA) and adjusted to 100 ng,
with the exception of plasma where 10 uL were directly
used since it was not possible to quantify the gDNA. In
order to obtain the standard DNA for absolute quantifi-
cation, gDNA was extracted from the BCBL-1 cell line
and the DNA copy numbers was determined by spectro-
photometer as well. Then, the OD concentration was
converted to DNA copy number following methods
published elsewhere [2]. Once the gDNA copy number
from BCBL-1 cell line was calculated, it was adjusted to
1 million copies and a standard curve with serial ten-
fold dilutions (from 10
6 to 10 copies) assayed in tripli-
cates was prepared. Once the run finished, the standard
curve was automatically generated by the LightCycler
software version 3.3, using the Second Derivative Maxi-
mum (SDMM) method. In additon, the detection of
Human b globin gene was used as internal control in
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any medium, provided the original work is properly cited.each clinical sample (with exception of plasma) for mea-
suring of the exact amount of input DNA [3].
RT-PCR primers and conditions were described pre-
viously by Watzinger et al [4] with minor modifications
adapted for the LightCycler 1.5 [4]. Samples were con-
sidered negative if the Ct value exceeded cycle 40, or if
the copy number was below 10 copies. All patients or
samples with more than 10 copies were considered posi-
tive, thus infected with HHV-8. For statistical analysis
SPSS 11,5 (Inc. SPSS, Chicago, IL, the USA) and Stat-
graphic were used. Tests for comparison of proportions
between the averages were performed using the Chi-
square test and the Pearson coefficient of correlation for
95% confidentiality.
To our knowledge, this is the first report, where
HHV-8 viral load has been simultaneously determined
in four different fluids and cells (affected tissue, saliva,
plasma and PBMC) from the same AIDS-KS patients.
Forty-eight (98%) of the 49 AIDS-KS patients had
detectable levels of HHV-8 DNA at least in one of the
samples studied, (67% of patients had more than 2 sam-
ples positives), with the virus being more frequently
detected in KS lesions (44 tissues, 91.6%) followed by
saliva in 78% and PBMC in 69.2%. The detection prob-
ability and viral load being significantly lower in plasma
(37%). There was a positive correlation between the
detection of HHV-8 in tissue and the detection in saliva
or PBMC (p < 0.01) that was not observed for plasma
(Table 2). Although PCR inhibitions could be a possible
explanation for the 4 negative results from KS lesions,
several other factors that may have limited KSHV detec-
tion, like lesion sampling, since the lesion sample was
not always the same for molecular detection and diag-
nosis. In addition, a possible histological inaccuracy
could not be excluded because some patients were diag-
nosed as early stage of KS [5]. However, the percentage
of KSHV DNA detected in the present study is similar
to previous results published by Mendez and colleagues
[6] and higher than the 87% of KSHV DNA detection
reported by Kennedy and co-authors [7].
All fresh frozen tissues, PBMC and saliva samples, were
confirmed to have the same amount of the input gDNA
in100 ng, by detecting similar crossing point (Cp) ampli-
fication signal of the Human b globin gene among them
(average Cp: 24.08, range: 22-25); in contrast, paraffin-
embedded tissues showed a gDNA amplification signal
after cicle 29 (range:27-32), probably due to degradation
[8]. This result was consistent with the detection of
HHV-8 load significantly higher in fresh frozen tissue
than in paraffin-embedded tissue (p < 0.003) (Table 2).
Despite the difference detected between fresh frozen
and paraffin-embedded tissue, when copy numbers from
Table 1 Demographical, epidemiological and clinical characteristic of the study population
Demographical, epidemiological and clinical variables AIDS-KS N = 49
Mean Age 38.2 years (Range: 22-57)
Gender Female 2 (4.1%)
Male 47 (95.9%)
Race White 35 (71.4%)
Mulatto 9 (18.4%)
Black 5 (10.2%)
Sexual orientation Heterosexual 5 (10.2%)
Homosexual 44 (89.8%)
Type of KS according to macroscopic classification Cutaneous 35 (71.4%)
Mucocutaneous 7 (14.3%)
Disseminated 7 (14.3%)
Histological classification Macular 16 (32.6%)
Patch 7 (14.3%)
Tumor 14 (28.6%)
Not classified 12 (24.5%)
Mean HIV viral load* (copies/mL) 65 135 (Range: < 50-580 000)
Mean T CD4+ cell count (cel/mm
3) 295 (Range: 8-974)
T CD4+ cell count < 200 21 (42.9%)
200-499 21 (42.9%)
> 500 7 (14.2%)
Mean number of years after KS diagnosis 1.6 years
*Data not available from 7 patients.
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ID Tissue copies/100 ng gDNA PBMC copies/100 ng gDNA Saliva copies/100 ng gDNA Plasma copies/uL
ADS-KS1 293 (fresh frozen tissue) 41 71 ndt
ADS-KS2 28200 (fresh frozen tissue) 32 193 ndt
ADS-KS3 17670 (fresh frozen tissue) 22 134 ndt
ADS-KS4 51610 (fresh frozen tissue) 130 62 ndt
ADS-KS5 294 (fresh frozen tissue) ndt 269 92
ADS-KS6 167 (paraffin embedded) 40 130 ndt
ADS-KS7 15850 (fresh frozen tissue) ndt ndt ndt
ADS-KS8 30000 (fresh frozen tissue) ndt 145 ndt
ADS-KS9 ndt (paraffin embedded) ndt ndt ndt
ADS-KS10 78 (paraffin embedded) 119 121 239
ADS-KS11 1952 (fresh frozen tissue) 38 191 39
ADS-KS12 21840 (fresh frozen tissue) 390 96 49
ADS-KS13 529 (paraffin embedded) ndt ndt 2452
ADS-KS14 37630 (fresh frozen tissue) ndt 394 ndt
ADS-KS15 26090 (fresh frozen tissue) 19 ndt ndt
ADS-KS16 57 (paraffin embedded) ndt 77 ndt
ADS-KS17 23 (paraffin embedded) ndt 49 68
ADS-KS18 477 (paraffin embedded) 307 23 30
ADS-KS19 42 (paraffin embedded) 31 160 ndt
ADS-KS20 1725 (fresh frozen tissue) ndt 145 ndt
ADS-KS21 ndt (fresh frozen tissue) 42 2482 ndt
ADS-KS22 0 (fresh frozen tissue) 40 584 ndt
ADS-KS23 22 (paraffin embedded) 26 343 20
ADS-KS24 1418000 (fresh frozen tissue) 19 236 65
ADS-KS25 36460 (fresh frozen tissue) 167 32 55
ADS-KS26 749 (fresh frozen tissue) NS 172 NS
ADS-KS27 47050 (fresh frozen tissue) NS NS NS
ADS-KS28 58 (fresh frozen tissue) NS ndt NS
ADS-KS29 389 (fresh frozen tissue) NS ndt NS
ADS-KS30 39830 (fresh frozen tissue) NS 89 NS
ADS-KS31 10040 (paraffin embedded) NS NS NS
ADS-KS32 819 (fresh frozen tissue) NS NS NS
ADS-KS33 128800 (fresh frozen tissue) NS 445 NS
ADS-KS34 ndt (fresh frozen tissue) NS 366 NS
ADS-KS35 206 (fresh frozen tissue) NS ndt NS
ADS-KS36 68280 NS 114 ndt
ADS-KS37 877 (paraffin embedded) NS NS NS
ADS-KS38 30730 (fresh frozen tissue) NS 131 NS
ADS-KS39 NS 53 9447 ndt
ADS-KS40 867 (paraffin embedded) NS ndt NS
ADS-KS41 30520 (fresh frozen tissue) NS 148 NS
ADS-KS42 35 (fresh frozen tissue) NS NT NS
ADS-KS43 31740 (fresh frozen tissue) NS 177 NS
ADS-KS44 10120 (fresh frozen tissue) NS 132 NS
ADS-KS45 139800 (fresh frozen tissue) NS NS NS
ADS-KS46 2483 (fresh frozen tissue) NS ndt NS
ADS-KS47 163 (fresh frozen tissue) NS NS NS
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PBMC, plasma-saliva, PMBC-saliva, and PBMC-plasma)
within a given individual were compared, a significantly
higher HHV-8 viral load in KS lesions compared to all
the other samples (p < 0.05) was detected (Figure 1).
One of the reasons that may explain why the higher
HHV-8 load is detected in tissue, specifically in the case
of HIV infection, is that the HIV tat protein promotes
the replication of HHV-8-stimulated cell proliferation
and inhibits apoptosis of spindle cells infected with
HHV-8 [9,10]. Recent reports have described a higher
HHV-8 load of AIDS-KS lesions compared with ende-
mic KS, although the differences were not statistically
significant.
HHV-8 load in saliva and PBMC was significantly
lower than in tissue (p < 0.05) and significantly higher
than in plasma (p < 0.05; Figure 1), however there were
no statistic differences between the viral load in saliva
a n dP B M C( p>0 . 0 5 ) .O fn o t e ,s a l i v ar e p r e s e n t e dt h e
second most frequent source for HHV-8 detection (Fig-
ure 1). In the light of previous reports [11-13] and con-
sistent with the present results transmission by saliva
may contribute to the spread of HHV-8 infection
among the HIV seropositive population besides sexual
intercourse [14]. It still remains controversial why, if sal-
iva is the main source of virus, HHV-8 infection shows a
sexual pattern of transmission. Nevertheless, saliva is the
only mucosal fluid in which infectious HHV-8 has been
Table 2 KSHV load levels in different fluid and cells from each KS patient (Continued)
ADS-KS48 28680 (fresh frozen tissue) NS 230 NS
ADS-KS49 58 (paraffin embedded) NS NS NS
Abbreviations: Ndt: non detectable; NS: no sample available.
Figure 1 Comparison of the logarithmic KSHV load detected in different samples of epidemic KS patient using the RT-PCR assay of a
conserved region of ORF-26.
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vary shedding remain unclear [15]. Moreover, future
research will need to assess the possible impact of saliva
in HHV-8 transmission among Cuban HIV seronegative
individuals.
Most authors agree that the viral genome present in
PBMC of AIDS-KS patients occurs in a latent state, but
the role of HHV-8 persistence in PBMC with regard to
the pathogenesis of KS remains unclear [16]. The lower
copy number of HHV-8 detected in PBMC in compari-
son to KS tissue, could be due to its latent state within
this compartment, in contrast to viral expression present
in lesional spindle cells [17].
Harrington and colleagues demonstrated that the pre-
sence of HHV-8 in plasma is intermittent [18]. For
other viral infections, plasma viral load has been used as
the best marker to estimate disease progression [19-21].
However, this does not seem to be true for KS and
HHV-8, as has been proposed by Polstra and colleagues
[22]. Hundred percent of Cuban AIDS-KS patients, in
whom HHV-8 was detected in plasma also tested posi-
tive in other clinical samples (saliva, KS tissue, PBMC).
Thus, viremia could occur in those patients with active
viral replication, alternating with latency periods where
the virus is not detected in plasma, as has been reported
for other members of the Herpesviridae family [23].
There was a significant Pearson’s correlation when
each patient’s tissue HHV-8 levels were compared with
saliva and PBMC (p < 0.01); however, this correlation
did not exist for plasma samples (Figure 2). We did not
find association between the HHV-8 viral load in all the
samples analyzed with: CD4 cell counts, HIV viral load,
type of KS (cutaneous, mucocutaneous and systemic),
the histological stage (macular, patch and tumoral) nor
the number of years elapsed between the KS diagnosis
and death (p > 0.05).
In our study, Caucasian AIDS-KS patients were more
likely to be positive for HHV-8 infection than black or
mulatto KS patients (p = 0.006). There is no previous
report regarding the association of HHV-8 levels with
skin color. However, it has been described several times
that AIDS-KS is more frequent in individuals with white
skin [24]. Some authors have proposed a genetic predis-
position to HHV-8 infection in individuals with certain
HLA types (A*6801 and DRB1*04) that tend to have
increased viral excretion in saliva e.g. in African women
[25]. MSM were more likely to have three-times higher
HHV-8 genome copies in KS lesions when compared
with tissues from heterosexuals individuals (OR 3; 95%
CI 1.1 to 12.5). This seems to be a very important find-
ing that confirms what has been reported by other
authors regarding sexual risk behaviors that are more
prevalent in homosexual intercourse [26]. With the pre-
sent study we confirm that HHV-8 produces a systemic
infection in different body compartments and that the
highest HHV-8 levels were produced in lesional KS tis-
sue. Furthermore, saliva has been recognized as an
important reservoir for HHV-8 transmission.
One of the main challenges for researchers is to iden-
tify the exact mode of virus transmission following
Figure 2 Graphic representation of KSHV loads in different samples per each AIDS-KS patient.
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Page 5 of 7sexual intercourse, as the presence of HHV-8 in semen,
anal secretions or vaginal fluid has not been consistently
demonstrated [27-30].
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